Novo Nordisk | driving change to defeat serious chronic diseases
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Who we are - Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
Careers - Novo Nordisk
At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
Our products - Novo Nordisk
Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Latest news - Novo Nordisk
Dec 20, 2024 · Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
Healthcare professionals | Novo Nordisk | Driving Change
Novo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page
Our heritage | Novo Nordisk | Driving change
Today, NovoPen ® is a design icon and Novo Nordisk continues to pioneer delivery systems that improve quality of life and make managing chronic diseases easier. The Novo Syringe from 1925 and the first NovoPen ® device from 1985
About us - Novo Nordisk
Facts about Novo Nordisk such as employee figures, financial figures and our positions.
Career areas - Novo Nordisk
A career at Novo Nordisk is more than just a job. It’s an opportunity to improve the lives of millions of people living with serious chronic disease, while also developing yourself along the way.
Novo Nordisk Annual Report 2023
Novo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page